ScholarLens Back to search
1997•Clinical and Experimental DermatologyRequires access

The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis

J.F. BURKE, S. J. Iqbal, P.E.H. TCHINSON

Open publisher page 0 citations

Abstract

We studied the effects of combining topical calcipotriol, used at the maximal licensed dose, and narrow‐band short wave ultraviolet light (TL01) on systemic calcium homeostasis in the treatment of chronic plaque psoriasis. Patients were randomized in an open fashion to receive either UVB alone, UVB plus 100 g of calcipotriol (50 μg/g) ointment per week or calcipotriol ointment alone (100 g/week). With the exception of a slight increase in serum phosphate in the group receiving combination therapy (from 0·92 to 1·22 mmol/l; P= 0·046), no differences were observed between or within the groups. Psoriasis area and severity scores (PASI) improved to a greater extent in those patients receiving both UVB and calcipotriol (P= 0·045). The combination of UVB and calcipotriol is a safe, effective treatment for chronic plaque psoriasis.

About this research paper

What this paper is about

We studied the effects of combining topical calcipotriol, used at the maximal licensed dose, and narrow‐band short wave ultraviolet light (TL01) on systemic calcium homeostasis in the treatment of chronic plaque psoriasis. Patients were randomized in an open fashion to receive either UVB alone, UVB plus 100 g of calcipotriol (50 μg/g) ointment per week or calcipotriol ointment alone (100 g/week). With the exception of a slight increase in serum phosphate in the group receiving combination therapy (from 0·92 to 1·22 mmol/l; P= 0·046), no differences were observed between or within the groups. Psoriasis area and severity scores (PASI) improved to a greater extent in those patients receiving both UVB and calcipotriol (P= 0·045). The combination of UVB and calcipotriol is a safe, effective treatment for chronic plaque psoriasis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We studied the effects of combining topical calcipotriol, used at the maximal licensed dose, and narrow‐band short wave ultraviolet light (TL01) on systemic calcium homeostasis in the treatment of chronic plaque psoriasis. Patients were randomized in an open fashion to receive either UVB alone, UVB plus 100 g of calcipotriol (50 μg/g) ointment per week or calcipotriol ointment alone (100 g/week). With the exception of a slight increase in serum phosphate in the group receiving combination therapy (from 0·92 to 1·22 mmol/l; P= 0·046), no differences were observed between or within the groups. Psoriasis area and severity scores (PASI) improved to a greater extent in those patients receiving both UVB and calcipotriol (P= 0·045). The combination of UVB and calcipotriol is a safe, effective treatment for chronic plaque psoriasis.

Key concepts: Calcipotriol, Medicine, Plaque psoriasis, Psoriasis, Dermatology, Ultraviolet therapy, Psoriasis Area and Severity Index, Ultraviolet light

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis — Research Paper | ScholarLens